Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-12

FDA Approved: MOMETASONE FUROATE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Cosette Pharmaceuticals, Inc.'s supplemental application for mometasone furoate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mometasone furoate (Mometasone furoate)

Snippet

SUPPL AP for MOMETASONE FUROATE (MOMETASONE FUROATE)